House Republicans Ask FDA To Expand Parallel Track Pathway

By Beth Wang / July 18, 2019 at 2:38 PM
House Republicans want FDA to expand the Parallel Track pathway, which currently provides patients with HIV and AIDS drugs that have not been FDA approved but are being studied in clinical trials, to include potential therapies for debilitating diseases such as Alzheimer’s and cancer. The lawmakers’ request echoes one made by a group of Republican senators in May . In a letter sent to FDA Acting Commissioner Ned Sharpless Thursday (July 11), 11 House Republicans say FDA’s Parallel Track program...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.